Results 21 to 30 of about 16,685 (240)

An update on polymyalgia rheumatica

open access: yesJournal of Internal Medicine, 2022
Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease affecting people older than 50 years and is 2–3 times more common in women.
I. Lundberg   +3 more
semanticscholar   +1 more source

Acute cholangitis following mRNA COVID-19 vaccine booster in a patient receiving an anti-amyloid antibody for Alzheimer’s disease: A case report

open access: yesSAGE Open Medical Case Reports, 2023
A 77-year-old woman had 2 weeks of fever and flu-like symptoms starting several hours after receiving an mRNA booster for SARS-CoV-2 and the influenza vaccine, in separate shots. Laboratory tests showed cholangitis.
Linda L Restifo, Robert P Erickson
doaj   +1 more source

Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis

open access: yesClinical Rheumatology, 2021
A systematic review and meta-analysis were conducted, according to the PRISMA methodology, to summarize current evidence on the prevalence and predictors of long-term glucocorticoid (GC) treatment and disease relapses in the real-life management of ...
A. Floris   +7 more
semanticscholar   +1 more source

Vertebral osteomyelitis and epidural abscess due to Listeria monocytogenes – case report and review of literature [PDF]

open access: yesJournal of Bone and Joint Infection, 2022
We describe a case of native vertebral osteomyelitis (NVO) secondary to Listeria monocytogenes in a patient with polymyalgia rheumatica receiving chronic steroids.
O. I. Adebolu   +4 more
doaj   +1 more source

Polymyalgia rheumatica [PDF]

open access: yesBMJ, 2008
Polymyalgia rheumatica (PMR) is a common chronic inflammatory rheumatic disease with unknown aetiology, affecting predominately people of middle age and older. Besides clinical symptoms and diagnostics, imaging techniques including sonography and magnetic resonance imaging may provide evidence of typical inflammatory lesions with bilateral bursitis ...
Clement J, Michet, Eric L, Matteson
openaire   +4 more sources

Polymyalgia rheumatica in the 2018–2020 guidelines. Part II: diagnosis of vasculitis

open access: yesBolʹ, Sustavy, Pozvonočnik, 2021
The issue of improved diagnosis of both rheumatic diseases of the elderly and aortic diseases does not lose its relevance. In terms of aortic aneurysms, dissection and ruptures and their attended pathogenesis, both inflammation and structural wall ...
О.H. Puzanova, А.А. Lyzikov
doaj   +1 more source

Polymyalgia rheumatica as uncommon adverse event following immunization with COVID‐19 vaccine: A case report and review of literature

open access: yesAging Medicine, 2021
Polymyalgia rheumatica following immunization with Covid‐19 mRNA vaccine: TRL‐7 and TRL‐9 as common link.
C. Manzo, M. Natale, A. Castagna
semanticscholar   +1 more source

New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine

open access: yesInternal medicine, 2021
We herein report the case of an 80-year-old Japanese woman who presented to our hospital with bilateral pain in the shoulders and hips lasting for a month since 2 days after the second dose of the BNT162b2 COVID-19 vaccine.
A. Osada   +3 more
semanticscholar   +1 more source

Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination

open access: yesInternal medicine, 2021
Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease characterized by stiffness and aching mainly in the shoulders, neck and hip girdles.
S. Izuka   +4 more
semanticscholar   +1 more source

Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature

open access: yesRheumatology, 2021
Objectives Fast-track clinics (FTC) have been introduced in different fields and have been reporting significant outcomes in terms of reducing mortality, morbidity, and financial costs.
E. Hysa   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy